Related Experiment Video
Updated: Jun 6, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
Chittari Pabba1, Brian T Gregg, Douglas B Kitchen
1AMRI, Medicinal Chemistry Department, 30 Corporate Circle, PO Box 15098, Albany, NY 12212, USA. brian.gregg@amriglobal.com
Abstract:
A series of novel hydroxamic acid based histone deacetylases (HDAC) inhibitors with aryl ether and aryl sulfone residues at the terminus of a substituted, unsaturated 5-carbon spacer moiety have been synthesized for the first time and evaluated. Compounds with meta- and para-substitution on the aryl ring of ether hydroxamic acids 19c, 20c, 19e, 19f and 19g are potent HDAC inhibitors with activities at low nanomolar levels.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Enzyme Inhibition
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

